SARS-CoV-2/COVID-19 Research

A Smart Solution for Your Clinical Trial

Rules-Based Medicine (RBM), a Q² Solutions Company, is a CLIA certified, multiplexed immunoassay testing laboratory that solves complex drug development challenges with innovative biomarker services. RBM’s internally developed and manufactured immunoassay kits based on Multi-Analyte Profiling (MAP) and ultrasensitive Single-Molecule Array (Simoa^TM) technology, provide reproducible and quantitative data for hundreds of human proteins.

Ultrasensitive Immunoassays
Quantify extremely low levels of low abundant protein analytes in serum or plasma with single molecule array (Simoa™) ultrasensitive immunoassays.

> Learn More

Multiplexed Immunoassays
Provide insight into multiple biological pathways to help better understand the underlying disease biology and therapeutic effects with a focus on the immune system and its interaction with other growth and tissue factors.

> Learn More

Custom Multi-Analyte Profiles (MAPs)
Choose a custom set of preconfigured multiplex protein biomarker panels specific to a therapy area or drug mechanism of action for accurate and reproducible pharmacodynamic data.

> Build Your Custom MAP

Immunomonitoring Made Simple
A whole-blood collection and leukocyte culture system for standardized, pharmacodynamic immune-phenotyping studies.

> Learn More

Why Choose RBM for your Clinical Trial

RBM’s long history of immunoassay development, manufacturing, and optimized robotic operation integrated throughout the testing process allows us to provide customers with unmatched expertise and quality for pharmacodynamic protein biomarker testing in clinical trials. We have developed automated systems and processes in a tightly controlled environment which produces highly reproducible results.

Our long history of developing and validating assays allows us to provide customers with unmatched expertise in the field of biomarker testing.

We have quality control measures in place for each and every step of the process, all in accordance with our strict standard operating procedures.

All of the data that we produce is inspected both automatically and manually to validate the standard curves, verify three-level controls, and double-check the sample results themselves.

Four step quality control procedure including instruments diagnostics, calibrator curves at front an back end of each reaction plate, three levels of controls run in duplicate, and sample review.